01 401BOEHRINGER INGELHEIM
01 1610258637*PED
02 410596120*PED
03 410610489*PED
04 211033552*PED
05 1611090323*PED
06 511813275*PED
07 1611833166*PED
08 1612115179*PED
09 612364700*PED
10 67407955
11 67407955*PED
12 167579449
13 167579449*PED
14 167713938
15 167713938*PED
16 88551957
17 88551957*PED
18 28673927
19 28673927*PED
20 68883805
21 68883805*PED
22 49155705
23 29173859
24 49415016
25 209949997
26 129949998
27 410022379
28 1610258637
29 410406172
30 1610596120
31 410610489
32 211033552
33 1611090323
34 311564886
35 911666590
36 611813275
37 3211833166
38 1612115179
39 212178819
40 1012263153
41 612364700
42 109949997*PED
43 109949998*PED
01 38Y
02 363Blank
01 79Y
02 322Blank
01 62025-05-02
02 62025-11-02
03 62025-11-26
04 62026-05-26
05 162027-04-15
06 82027-05-04
07 162027-10-15
08 42027-11-04
09 162028-08-01
10 162029-02-01
11 82029-04-02
12 82029-10-14
13 162030-02-11
14 82030-04-14
15 42030-05-21
16 42030-06-15
17 162030-08-11
18 42030-09-30
19 42031-03-30
20 192032-03-07
21 42032-09-07
22 892034-04-03
23 202034-05-17
24 122034-06-11
25 532034-10-03
26 102034-11-17
27 102034-12-11
28 62037-06-08
29 62037-12-08
Patent Expiration Date : 2027-05-04
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1772
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2034-06-11
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 206073
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-06-11
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-06-11
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-06-11
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-05-17
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-2292
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
